August
12
/ 2020
Flexi-Cap and Booklet-Label for Clinical Research
Oberschleissheim, August 12, 2020 – For an international Phase III study of a new immunoglobolin, CSL Behring relies on a novel label combination from Schreiner MediPharm: With a special Flexi-Cap version that completely covers the vial and a Booklet-Label for multilingual product information, the vials containing the drugs to be tested are reliably blinded.